April 27, 2015
A team of international researchers developed a profile identifying risk factors for malignancy progression in intraductal papillary mucinous neoplasms of the pancreas.
“The factors we found that increase risk of pancreatic cancer now allow us to separate patients as either low or high risk. High-risk patients can then be scanned and biopsied more frequently or can opt for surgery, but low-risk patients don’t need such surveillance,” Michael B. Wallace, MD, MPH, from Mayo Clinic in Jacksonville, Fla., said in a press release. “Pancreatic cancer is difficult to detect early — most patients are diagnosed at later stages when it’s 95% fatal — so we’re seeking ways to understand who is at risk.”